Boosh Announces the Granting of a Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - August 1, 2023) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or...
Nutrition
THIRA Health Jump-Starts Its Adolescent Residential Treatment Program
BELLEVUE, WA / ACCESSWIRE / August 1, 2023 / Bellevue, Washington-based mental wellness center THIRA Health is excited to announce...
Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing
SAN DIEGO, CA / ACCESSWIRE / August 1, 2023 / Prometheus Laboratories Inc. ("Prometheus") today announced a collaboration with Fresenius...
Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)
Napo Pharmaceuticals, a Jaguar Health company and the manufacturer of crofelemer, is supporting this physician-generated INDSAN FRANCISCO, CA / ACCESSWIRE...
Justin Esposito Discusses His Role As a Life Coach In New Online Interview
MIAMI, FL / ACCESSWIRE / July 31, 2023 / Justin Esposito is a celebrated life coach and fitness instructor. As...
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today...
Smart for Life Announces Greens First Product Line Now Available on Kroger’s Vitacost.com
Vitacost.com, Owned by The Kroger Co., Added 19 Greens First Products to its Online PlatformMIAMI, July 28, 2023 (GLOBE NEWSWIRE)...
Fortifeye Vitamins Unveils the Cutting-Edge, Next Gen, Zinc-Free Macular Defense Formula, Elevating Eye Health to New Heights
Fortifeye Vitamins Releases Next Gen, Zinc-Free Macular DefenseOCALA, FL / ACCESSWIRE / July 28, 2023 / Fortifeye Vitamins, a pioneering...
Avoiding the Unpleasant Side Effects of ED Drugs
Erectile Dysfunction Is a Common Struggle That Many Men Treat With Strong Chemical Drugs That Come With Side Effects. Male...
America’s Looming Health Crisis: The Chronic Disease Epidemic
As chronic disease becomes the norm, Cedrick Wellness Resources is calling for a nutrition-first approach to win the war on...
Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHIS’s SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil
Camelina containing the omega-3 EPA trait Camelina containing the omega-3 EPA trait growing at acre-scale in the U.S. in spring...
BPGbio and VELL Health Collaborate to Launch Revolutionary Global Health Initiative to Improve Type 2 Diabetes Outcomes in Guyana
Partnership supports Guyana’s launch of their Wellness Initiative to promote a healthier lifestyle among its citizensBOSTON--(BUSINESS WIRE)--BPGbio, Inc., a leading...
Fortifeye Vitamins Breaks New Ground With Next Gen Zinc-Free Macular Degeneration Formula
Fortifeye Vitamins Introduces Next Gen Zinc-Free Macular DefenseOCALA, FL / ACCESSWIRE / July 25, 2023 / Fortifeye Vitamins, a leading...
Justera Health Completes the Acquisition of Juillet Wellness Centre
Toronto, Ontario--(Newsfile Corp. - July 25, 2023) - Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the "Company")...
Dyadic Provides Phase 1 Clinical Trial Update for its Recombinant Protein RBD Vaccine Candidate
Dosing of patients completed at the end of FebruaryData Safety Monitoring Board conducted analysis of Day 29 data No major...
International Self-Care Day: Better Self-Care, Better Healthcare; Better Welfare Globally
Continued calls for WHO resolution on self-careNYON, SWITZERLAND / ACCESSWIRE / July 24, 2023 / International Self-Care month 2023 opened...
Correction: Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome
Positive opinion from Committee for Medicinal Products for Human Use (CHMP) based on Bylvay Phase III ASSERT clinical-trial data in...
Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome
Positive opinion from Committee for Medicinal Products for Human Use (CHMP) based on Bylvay Phase III ASSERT clinical-trial data in...
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Health
Recent Pentech Health acquisition of ZOIA Pharma broadens distribution and access for patients to PKU GOLIKE®GENEVA, SWITZERLAND / ACCESSWIRE /...
BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...